Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case–control study

BACKGROUND: Placenta accreta spectrum (PAS) disorder is a major cause of postpartum hemorrhage-associated maternal and fetal death, and novel methods for PAS screening are urgently needed for clinical application. METHODS: The purpose of this study was to develop new methods for PAS screening using...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiayi, Yang, Si, Xu, Xingneng, Xu, Xiuting, Wang, Xuwei, Ye, Anqi, Chen, Yanhong, He, Fang, Yu, Bolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334543/
https://www.ncbi.nlm.nih.gov/pubmed/37434137
http://dx.doi.org/10.1186/s12884-023-05784-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334543/
https://www.ncbi.nlm.nih.gov/pubmed/37434137
http://dx.doi.org/10.1186/s12884-023-05784-2

Ejemplares similares